Voxzogo 0.4 mg powder and solvent for solution for injection
Sponsors
Biomarin Pharmaceutical Inc.
Conditions
AchondroplasiaHypochondroplasia
Phase 3
A Phase 3, Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children with Achondroplasia
Active, not recruitingCTIS2023-508864-31-00
Start: 2019-04-03Target: 22Updated: 2025-03-28
A Phase 3, Open-Label, Long-Term Extension Study to Evaluate the Safety and Efficacy of Vosoritide in Children with Hypochondroplasia
Not yet recruitingCTIS2024-517238-16-00
Target: 44Updated: 2025-11-13